EUVIMEDEUVIMED entdecken
Crossref

Clinical Performance of Ultra‐Porous TiO 2 Scaffold as Bone Graft Substitute in Human Alveolar Ridge Preservation—A Feasibility Study

Ingvild Nysæther, Håvard Jostein Haugen iD, Thaqif El Khassawna, Reem Jamous, Shoresh Afnan, Marco Santacroce, Linda Z Arvidsson, Torben Hildebrand, S Petter Lyngstadaas, Jan Eirik Ellingsen

Clinical Oral Implants Research · 2026

DOI: 10.1111/clr.70074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Implants Research, 2026. Verfasst von Ingvild Nysæther und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery and Oral Medicine, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway. Hauptthemen laut MEDLINE: Titanium, Tissue Scaffolds, Alveolar Ridge Augmentation, Bone Substitutes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study evaluates the safety and osteoconductive potential of a ceramic TiO 2 scaffold in human alveolar bone, hypothesising that placement in human extraction sockets is safe, supports bone ingrowth and preserves ridge dimensions. Material and Methods Nine subjects requiring the extraction of ≥ 1 premolar or molar tooth were enrolled. Full‐thickness mucoperiosteal flaps were elevated. Following tooth extraction, porous ceramic TiO 2 scaffolds were adjusted chair‐side, placed into the extraction socket and covered by a resorbable collagen membrane. After 6 months of healing, before dental implant placement, a biopsy was performed at the site where the scaffold had been placed. Histomorphometric and micro‐CT analyses were made. CBCT images were made at baseline and at 6 months to assess alveolar ridge dimensional changes. Implants placed in regenerated bone were followed for 21 months.

Results

Scaffold customisation with chairside adjustment was straightforward. No serious adverse events were observed during the 6 months following scaffold implantation. One scaffold was removed due to an early exposure, while the remaining 9 scaffolds successfully integrated. Two sites presented with minor soft tissue dehiscences at 1–2 weeks, which healed spontaneously. Micro‐CT and histology confirmed new bone formation. Soft tissue healing was favourable, with no adverse reactions. Dimensional analysis revealed minimal changes in alveolar ridge width and height, indicating effective preservation of volume.

Conclusions

This clinical study confirms that TiO 2 scaffolds are a safe and effective option for promoting bone regrowth and preserving volume in human alveolar bone, thereby facilitating bone formation and maintaining ridge dimensions post‐extraction. Trial Registration This trial was registered at ClinicalTrials.gov (NCT06269497) on 1 December 2022

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TitaniumTissue ScaffoldsAlveolar Ridge AugmentationBone SubstitutesHumansMaleFemaleMiddle AgedTooth ExtractionTooth SocketFeasibility StudiesAdultX-Ray MicrotomographyCone-Beam Computed TomographyPorosityBone RegenerationDental Implantation, EndosseousAlveolar ProcessAged

Stichwörter der Autor:innen

TiO2alveolar bone regenerationbiomaterialsbone graftbone tissue engineeringdental implantsmaxillofacial surgeryscaffold

Substanzen

Titaniumtitanium dioxideBone Substitutes

Autor:innen und Institutionen

  • Department of Oral Surgery and Oral Medicine, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway.
  • Department of Biomaterials, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway.
  • Department of Oral and Maxillofacial Surgery, Sunderby Hospital, Luleå, Sweden.
  • Experimental Trauma Surgery, Faculty of Medicine, Justus-Liebig University Giessen, Giessen, Germany.
  • Department of Maxillofacial Radiology, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway.
  • Department of Prosthetics and Oral Function, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway.

ORCID-Profile: Håvard Jostein Haugen

Förderung

  • Norges Forskningsråd

Zitieren

APA

Nysæther, I., Haugen, H. J., El Khassawna, T., Jamous, R., Afnan, S., Santacroce, M., Arvidsson, L. Z., Hildebrand, T., Lyngstadaas, S. P., & Ellingsen, J. E. (2026). Clinical Performance of Ultra‐Porous TiO 2 Scaffold as Bone Graft Substitute in Human Alveolar Ridge Preservation—A Feasibility Study. Clinical Oral Implants Research. https://doi.org/10.1111/clr.70074

Vancouver

Nysæther I, Haugen HJ, El Khassawna T, Jamous R, Afnan S, Santacroce M, et al. Clinical Performance of Ultra‐Porous TiO 2 Scaffold as Bone Graft Substitute in Human Alveolar Ridge Preservation—A Feasibility Study. Clinical Oral Implants Research. 2026. doi:10.1111/clr.70074

BibTeX
@article{Nysther2026,
  author = {Nysæther, Ingvild and Haugen, Håvard Jostein and El Khassawna, Thaqif and Jamous, Reem and Afnan, Shoresh and Santacroce, Marco and Arvidsson, Linda Z and Hildebrand, Torben and Lyngstadaas, S Petter and Ellingsen, Jan Eirik},
  title = {Clinical Performance of Ultra‐Porous TiO 2 Scaffold as Bone Graft Substitute in Human Alveolar Ridge Preservation—A Feasibility Study},
  journal = {Clinical Oral Implants Research},
  year = {2026},
  doi = {10.1111/clr.70074}
}
Kostenlos starten →